Labcorp Holdings Inc. (LH) Financial Statements
Labcorp Holdings Inc. (LH) reported trailing twelve-month revenue of $14.3B (up 6.4% year on year) and net income of $1.0B as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $1.2B.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
LHLabcorp Holdings Inc.Follow LH — free
—
Price chart with a free account
- Market cap
- 26.7B
- P/E TTM
- 27.2
- Dividend yield
- 0.9%
- 52-week
- —
- Next earnings
- 28 Oct, in 3 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2009 Dec 09 | FY2010 Dec 10 | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.69 | 5.00 | 5.54 | 5.67 | 5.81 | 6.01 | 8.68 | 9.55 | 10.31 | 11.33 | 11.55 | 13.98 | 13.14 | 11.86 | 12.16 | 13.01 | 13.95 | 14.35 | |
| Gross profit | 1.97 | 2.10 | 2.27 | 2.25 | 2.22 | 2.20 | 2.90 | 2.85 | 3.09 | 3.18 | 3.25 | 4.95 | 4.99 | 3.71 | 3.36 | 3.62 | 4.01 | 4.14 | |
| Operating income | 0.94 | 0.98 | 0.95 | 1.02 | 0.99 | 0.91 | 1.00 | 1.27 | 1.31 | 1.33 | 1.33 | 2.45 | 3.05 | 1.44 | 0.73 | 1.09 | 1.38 | 1.50 | |
| Pre-tax income | 0.88 | 0.92 | 0.87 | 0.94 | 0.92 | 0.83 | 0.73 | 1.07 | 1.08 | 1.27 | 1.10 | 2.22 | 2.89 | 1.24 | 0.57 | 0.96 | 1.11 | 1.23 | |
| Income tax | 0.33 | 0.34 | 0.33 | 0.36 | 0.34 | 0.31 | 0.29 | 0.36 | -0.16 | 0.38 | 0.28 | 0.66 | 0.69 | 0.23 | 0.19 | 0.21 | 0.23 | 0.23 | |
| Net income | 0.54 | 0.56 | 0.52 | 0.58 | 0.57 | 0.51 | 0.44 | 0.71 | 1.23 | 0.88 | 0.82 | 1.56 | 2.38 | 1.28 | 0.42 | 0.75 | 0.88 | 1.00 | |
| Diluted EPS ($) | 4.98 | 5.29 | 5.11 | 5.99 | 6.25 | 5.91 | 4.35 | 6.82 | 11.81 | 8.61 | 8.35 | 15.88 | 24.39 | 13.97 | 4.77 | 8.84 | 10.46 | 12.09 | |
| Diluted shares (bn) | — | 0.105 | 0.102 | 0.097 | 0.092 | 0.086 | 0.101 | 0.104 | 0.104 | 0.103 | 0.099 | 0.098 | 0.098 | 0.092 | 0.088 | 0.084 | 0.084 | — |
USD billions · SEC XBRL
Labcorp Holdings Inc. — questions
- What is Labcorp Holdings Inc.'s revenue?
- $14.3B over the twelve months to 2026-06-30, up 6.4% year on year, from its 10-Q and 10-K filings.
- What is Labcorp Holdings Inc.'s net income?
- $1.0B over the twelve months to 2026-06-30.
- What is Labcorp Holdings Inc.'s free cash flow?
- $1.2B over the twelve months to 2026-06-30.
- What are Labcorp Holdings Inc.'s diluted earnings per share?
- $12.09 over the twelve months to 2026-06-30.
Every figure on this page comes from Labcorp Holdings Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.